Abstract
MicroRNAs (miRNAs) are single-stranded, small non-coding RNAs that ate involved in the transcriptional and post-transcriptional regulation of gene expression. Recently, miRNAs were demonstrated to be effectively delivered to a target cell or tissue from a host cell via extracellular vesicles (EVs). These EVs can be detected in blood, urine, exhaled breath condensates, bronchoalveolar lavage fluid (BALF), and other fluids. miRNAs are generated by donor cells and then packaged into EVs and delivered with intact functionality. After being delivered to the target cells, they regulate the translation of their target genes and the function of the target cells. Thus, EV transported miRNAs have become a new method for intercellular communication. EV miRNA transfer is well-documented in various pulmonary diseases, such as chronic obstructive pulmonary disease (COPD), asthma, pulmonary hypertension, and acute lung injury (ALI). In this review, we summarize the novel findings of EV miRNA transfer, focusing on the roles of miR-210, miR-200, miR-17, miR-146a, miR-155, and other miRNAs that are transported from primary human bronchial epithelial cells (HBECs), BALF, mesenchymal stem cells, and dendritic cells.
Highlights
Extracellular vesicles (EVs) consist of a small lipid bilayer surrounding vesicles containing proteins, lipids, metabolites, and nucleic acids (Yáñez-Mó et al, 2015)
Many studies have begun to report the effects of miRNA transfer via extracellular vesicles (EVs) (Das and Halushka, 2015; Claßen et al, 2017). This transfer was shown to be mediated via intercellular communication between many types of cells in the respiratory system: endothelial cells (ECs), (Aliotta et al, 2016; Serban et al, 2016) bronchial epithelial cells (BECs), (Fujita et al, 2015) dendritic cells (DCs), (Alexander et al, 2015) mesenchymal stem cells (MSC),(Lee et al, 2012) and others (Table 1)
EV miRNAs can be delivered to recipient cells and alter their status and biological processes, which will affect the pathophysiology of lung diseases (Kubo, 2017; Nana-Sinkam et al, 2017)
Summary
Extracellular Vesicle MicroRNA Transfer in Lung Diseases. MiRNAs were demonstrated to be effectively delivered to a target cell or tissue from a host cell via extracellular vesicles (EVs). These EVs can be detected in blood, urine, exhaled breath condensates, bronchoalveolar lavage fluid (BALF), and other fluids. After being delivered to the target cells, they regulate the translation of their target genes and the function of the target cells. We summarize the novel findings of EV miRNA transfer, focusing on the roles of miR-210, miR-200, miR-17, miR-146a, miR-155, and other miRNAs that are transported from primary human bronchial epithelial cells (HBECs), BALF, mesenchymal stem cells, and dendritic cells
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
